Does Cinqair treat all types of asthma?
Medically reviewed by Drugs.com Last updated on Apr 12, 2019.
Official Answerby Drugs.com
No, Cinqair is used in more severe asthma with elevated eosinophils (a type of white blood cell) that has not responded well to initial treatments. Cinqair is an anti-interleukin-5 (IL-5) used in adults 18 years and older as an add-on therapy for the maintenance treatment of severe asthma in adults not well-controlled on their current asthma medications.
Cinqair (reslizumab) from Teva Pharmaceuticals, is not for initial asthma treatment, for less severe asthma, or for use as a rescue therapy.
In studies, patients receiving Cinqair had fewer asthma attacks, a longer time to first attack, and improvement in lung functions tests.
Common side effects with Cinqair include anaphylaxis (a severe, possibly life-threatening allergy), cancer, and muscle pain.
Related Medical Questions
- What is Nucala (mepolizumab) used for and how is it given?
- What type of asthma is Fasenra used to treat?
- What are the side effects of steroids?
- How is the new Primatene Mist different to the old formulation?
- Prednisone vs Prednisolone - What's the difference?
- Is Wixela Inhub the same as Advair Diskus?
- Does coffee help with asthma?
- Cinqair Information for Consumers
- Cinqair Information for Healthcare Professionals (includes dosage details)
- Side Effects of Cinqair (detailed)